Ovid Therapeutics's market cap is currently $44.47M. The company's EPS TTM is $-0.459; its P/E ratio is ―; Ovid Therapeutics is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 391.69K	$ 1.50M	$ 208.38M	$ 12.62M	$ 0.00
Gross Profit	$ 391.69K	$ 121.14K	$ 208.38M	$ 12.62M	$ -255.00K
Operating Income	$ -59.28M	$ -55.55M	$ 124.21M	$ -81.43M	$ -61.41M
EBITDA	$ -57.69M	$ -52.79M	$ 124.40M	$ -81.12M	$ -60.21M
Net Income	$ -52.34M	$ -51.41M	$ 122.83M	$ -80.73M	$ -59.26M
Balance Sheet
Cash & Short-Term Investments	$ 105.83M	$ 129.00M	$ 187.80M	$ 72.03M	$ 76.74M
Total Assets	$ 144.03M	$ 155.27M	$ 194.54M	$ 75.93M	$ 80.84M
Total Debt	$ 16.00M	$ 16.54M	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -11.04M	$ -112.47M	$ -187.80M	$ -72.03M	$ -41.90M
Total Liabilities	$ 56.23M	$ 22.99M	$ 14.80M	$ 32.29M	$ 10.82M
Stockholders' Equity	$ 87.80M	$ 132.27M	$ 179.75M	$ 43.63M	$ 70.02M
Cash Flow
Free Cash Flow	$ -45.92M	$ -56.65M	$ 118.42M	$ -51.97M	$ -51.33M
Operating Cash Flow	$ -45.78M	$ -55.23M	$ 118.61M	$ -51.58M	$ -51.09M
Investing Cash Flow	$ -2.58M	$ -87.88M	$ -1.82M	$ 34.65M	$ -30.04M
Financing Cash Flow	$ 30.54M	$ 180.66K	$ 904.08K	$ 47.07M	$ 86.54M

Currency in USD

Ovid Therapeutics Earnings and Revenue History

Income Statement >

Ovid Therapeutics Debt to Assets

Balance Sheet >

Ovid Therapeutics Cash Flow

Cash Flow >

Ovid Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing